ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
USFDA awards Breakthrough Therapy designation to Novartis’ asciminib pharmaceutical-business-review
February 10, 2021Novartis has announced that the novel investigational treatment asciminib, specifically targeting the ABL myristoyl pocket (STAMP), has been awarded Breakthrough Therapy designation (BTD) by the US Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
